Alternatively, IDH mutations promote gliomagenesis by disrupting chromosomal topology and allowing aberrant regulatory interactions that induce oncogene expression such as PDGFR (platelet-derived growth factor receptor) [39], the combination of which is frequently observed in the proneural subtype of GBM [40,41]. This evidence concerns the gene IDH1 and glioblastoma.